Yohan Suryo Rahmanto

3.8k total citations
46 papers, 3.0k citations indexed

About

Yohan Suryo Rahmanto is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yohan Suryo Rahmanto has authored 46 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Yohan Suryo Rahmanto's work include Cancer Mechanisms and Therapy (8 papers), Trace Elements in Health (8 papers) and Iron Metabolism and Disorders (7 papers). Yohan Suryo Rahmanto is often cited by papers focused on Cancer Mechanisms and Therapy (8 papers), Trace Elements in Health (8 papers) and Iron Metabolism and Disorders (7 papers). Yohan Suryo Rahmanto collaborates with scholars based in Australia, United States and Japan. Yohan Suryo Rahmanto's co-authors include Des R. Richardson, Louise Dunn, Prem Ponka, E. Becker, Megan Whitnall, Yu Yu, Michael Huang, Federica Saletta, Darius J.R. Lane and Alex D. Sheftel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yohan Suryo Rahmanto

46 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohan Suryo Rahmanto Australia 33 1.5k 666 601 516 349 46 3.0k
Michael Huang Australia 26 1.5k 1.0× 496 0.7× 553 0.9× 418 0.8× 254 0.7× 49 2.7k
Sumit Sahni Australia 35 1.9k 1.2× 273 0.4× 553 0.9× 1.1k 2.2× 122 0.3× 90 3.6k
Nelson S. Yee United States 30 1.2k 0.8× 180 0.3× 502 0.8× 780 1.5× 119 0.3× 83 3.0k
Masaya Ueno Japan 28 1.6k 1.0× 152 0.2× 103 0.2× 364 0.7× 140 0.4× 61 2.7k
Claudio Festuccia Italy 45 2.8k 1.8× 233 0.3× 118 0.2× 1.6k 3.1× 305 0.9× 164 5.3k
Manik C. Ghosh United States 38 2.1k 1.4× 1.9k 2.8× 1.3k 2.1× 405 0.8× 1.4k 4.0× 88 4.9k
Maura Poli Italy 32 1.3k 0.8× 1.4k 2.0× 825 1.4× 236 0.5× 700 2.0× 77 3.2k
Stephen Hiscox United Kingdom 36 2.1k 1.4× 164 0.2× 622 1.0× 1.4k 2.8× 114 0.3× 93 3.8k
Angel L. Armesilla United Kingdom 30 1.6k 1.1× 98 0.1× 170 0.3× 507 1.0× 80 0.2× 50 2.8k
Arthur J. Sytkowski United States 36 1.6k 1.1× 945 1.4× 142 0.2× 467 0.9× 224 0.6× 91 3.2k

Countries citing papers authored by Yohan Suryo Rahmanto

Since Specialization
Citations

This map shows the geographic impact of Yohan Suryo Rahmanto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohan Suryo Rahmanto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohan Suryo Rahmanto more than expected).

Fields of papers citing papers by Yohan Suryo Rahmanto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohan Suryo Rahmanto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohan Suryo Rahmanto. The network helps show where Yohan Suryo Rahmanto may publish in the future.

Co-authorship network of co-authors of Yohan Suryo Rahmanto

This figure shows the co-authorship network connecting the top 25 collaborators of Yohan Suryo Rahmanto. A scholar is included among the top collaborators of Yohan Suryo Rahmanto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohan Suryo Rahmanto. Yohan Suryo Rahmanto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asaka, Shiho, Ying Liu, Yohan Suryo Rahmanto, et al.. (2023). ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis. Modern Pathology. 36(2). 100045–100045. 12 indexed citations
2.
Shen, Yao, Jin Gyoung Jung, Geoffrey D. Shimberg, et al.. (2021). Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy. iScience. 24(11). 103297–103297. 17 indexed citations
3.
Shen, Yao, Jiaxin Hong, Shiho Asaka, et al.. (2020). Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. Cancer Research. 80(20). 4514–4526. 60 indexed citations
4.
Bae, Dong-Hun, Darius J.R. Lane, A. Rosemary Siafakas, et al.. (2020). Acireductone dioxygenase 1 (ADI1) is regulated by cellular iron by a mechanism involving the iron chaperone, PCBP1, with PCBP2 acting as a potential co-chaperone. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(10). 165844–165844. 10 indexed citations
5.
Rahmanto, Yohan Suryo, Wenjing Shen, Xu Shi, et al.. (2020). Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming. Nature Communications. 11(1). 2717–2717. 55 indexed citations
6.
Yu, Yu, Yohan Suryo Rahmanto, Yao Shen, et al.. (2019). Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer. EBioMedicine. 47. 184–194. 9 indexed citations
7.
Park, Youngran, M. Herman Chui, Yohan Suryo Rahmanto, et al.. (2019). Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Clinical Cancer Research. 25(18). 5584–5594. 95 indexed citations
8.
Gunosewoyo, Hendra, et al.. (2019). Therapeutic Inducers of Apoptosis in Ovarian Cancer. Cancers. 11(11). 1786–1786. 57 indexed citations
9.
Chen, Lin‐Yu, Rui Huang, Michael WY Chan, et al.. (2019). TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. The Journal of Pathology. 248(3). 363–376. 29 indexed citations
10.
Kaur, Pritinder, et al.. (2018). Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(2). 371–378. 41 indexed citations
11.
Lane, Darius J.R., Dong-Hun Bae, A. Rosemary Siafakas, et al.. (2018). Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2793–2813. 32 indexed citations
12.
Xing, Deyin, Yohan Suryo Rahmanto, Felix Zeppernick, et al.. (2017). Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma. Human Pathology. 68. 87–91. 16 indexed citations
13.
Rahmanto, Yohan Suryo, Danuta S. Kalinowski, Darius J.R. Lane, et al.. (2012). Nitrogen Monoxide (NO) Storage and Transport by Dinitrosyl-Dithiol-Iron Complexes: Long-lived NO That Is Trafficked by Interacting Proteins. Journal of Biological Chemistry. 287(10). 6960–6968. 55 indexed citations
14.
Correnti, Colin, Věra Richardson, Ashok D. Bandaranayake, et al.. (2012). Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines. PLoS ONE. 7(8). e43696–e43696. 40 indexed citations
15.
Rahmanto, Yohan Suryo, et al.. (2011). Melanotransferrin: Search for a function. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(3). 237–243. 42 indexed citations
16.
Saletta, Federica, Yohan Suryo Rahmanto, A. Rosemary Siafakas, & Des R. Richardson. (2011). Cellular Iron Depletion and the Mechanisms Involved in the Iron-dependent Regulation of the Growth Arrest and DNA Damage Family of Genes. Journal of Biological Chemistry. 286(41). 35396–35406. 40 indexed citations
17.
Kovačević, Žaklina, Danuta S. Kalinowski, David B. Lovejoy, et al.. (2011). The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer. Current Topics in Medicinal Chemistry. 11(5). 483–499. 67 indexed citations
18.
Rahmanto, Yohan Suryo, Louise Dunn, & Des R. Richardson. (2007). The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark – from iron metabolism to tumorigenesis. Oncogene. 26(42). 6113–6124. 52 indexed citations
19.
Rahmanto, Yohan Suryo, Louise Dunn, & Des R. Richardson. (2007). Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo. Carcinogenesis. 28(10). 2172–2183. 32 indexed citations
20.
Rahmanto, Yohan Suryo, et al.. (2006). Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates. Journal of Pharmacology and Experimental Therapeutics. 317(1). 153–162. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026